Divalproex Sodium Tablet, Extended Release
Product Images NDC 71335-1883

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-1883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

Chemical structure of divalproex sodium, depicting its molecular arrangement including carbon chains, carboxyl groups, and sodium ion (Na+). This structure represents the extended-release tablet ingredient.*

FDA Label Image

Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

A cumulative percentage plot showing the percent reduction in complex partial seizure (CPS) rate for patients treated with Divalproex Sodium Delayed-Release versus placebo. The vertical axis indicates the percent reduction in seizure rate, with improvement and worsening labeled, while the horizontal axis represents the percentage of patients.*

FDA Label Image

Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

A graph showing percent reduction in CPS rate on the vertical axis versus percent of patients on the horizontal axis, comparing high dose and low dose Divalproex Sodium Delayed Release. The graph indicates improvement or worsening in CPS rate among patients treated with these doses.*

FDA Label Image

Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

A bar graph comparing the effect of placebo versus Divalproex Sodium Extended-Release Tablets. The vertical axis measures a variable with values from 0 to 1.2. The placebo bar shows a value of 0.6, while the Divalproex Sodium bar reaches 1.2, marked as statistically significant (p=0.006).*

FDA Label Image

Label (Lbl713351883)

Label for Divalproex Sod. 500mg ER Tablet, an extended release oral tablet packaged by Bryant Ranch Prepack in Burbank, CA. The label references comparison to Depakote 500mg ER Tablet by Lupin Limited and includes storage instructions at 20°-25°C (68°-77°F) with a note to keep the container tightly closed. Package count is 60 tablets, with NDC 71335-1883-1 visible along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.